Clin2
NCT07118618Possibly a fitRecruiting

Probenecid for alcohol cravings and drinking

Alcohol Use Disorder (AUD)Alcohol ConsumptionCraving

Treatments studied

Part of Mental health clinical trials.

This study tests if the medication probenecid can help reduce cravings for alcohol and the amount you drink. It is for people who drink heavily and have moderate to severe alcohol use disorder.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • Women must drink more than 7 drinks per week, men more than 14 drinks per week.
  • You must have moderate to severe alcohol use disorder as defined by standard criteria.
  • You must be in good general health and have normal lab tests.
  • You cannot take certain other medications or have certain mental health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06136195Recruiting· Phase 1
Mavoglurant for alcohol craving in heavy drinkers

This trial tests whether a medication called mavoglurant can reduce alcohol cravings and drinking in people who are heavy drinkers with alcohol use disorder and are not looking for treatment.

New Haven, Connecticut
NCT04135846Recruiting· Phase 2
Alpha-blocker medicine to help reduce alcohol drinking

This Phase 2 trial tests whether blocking certain body signals (alpha receptors) with a study medicine can help people with alcohol use disorder cut down or stop drinking. You may be able to join if you meet alcohol-use criteria and can safely take the study drug.

Providence, Rhode Island
NCT05408247Recruiting· Phase 4
N-acetylcysteine to help people cut back on alcohol

This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.

Sydney, New South Wales
NCT07148843Not yet recruiting· Phase 2/Phase 3
CBD for Alcohol Withdrawal and Cravings

This study tests whether cannabidiol (CBD) can help reduce alcohol withdrawal symptoms and cravings when added to usual care. If you are a heavy drinker with alcohol use disorder and have experienced withdrawal, this trial may offer a new approach to manage cravings and safely quit drinking.

Baltimore, Maryland
NCT06636227Recruiting· Phase 1
Diclofenac dose study for alcohol use disorder

This study tests whether different doses of diclofenac, an anti-inflammatory drug, can help people reduce heavy drinking. It looks at how the drug affects drinking patterns and overall health.

Catonsville, Maryland
NCT07681869Not yet recruiting· Phase 2
Can nimodipine help reduce drinking?

This study tests whether a blood pressure medication called nimodipine can help reduce drinking in people with alcohol use disorder. If you are a heavy drinker and not seeking treatment right now, you may be able to join.

New Haven, Connecticut

Hear when a new Alcohol Consumption trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.